Oncology Pharma Inc (ONPH PINK) stock market data APIs
$0.1004
0(0%)
as of March 26, 2026
Try our APIs with
free plan!
Oncology Pharma Inc Financial Data Overview
Price chart is built with
Anychart
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Prev. Close
0.1004
Open
0.1004
High
0.1393
Low
0.0993
52 wk Range
0-0.2
Market Cap
3 796 K
Shares Outstanding
37 963 K
Revenue
10 214
EPS
0
Beta
0.814
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Oncology Pharma Inc data using free add-ons & libraries
Get Oncology Pharma Inc Fundamental Data
Oncology Pharma Inc Fundamental data includes:
- Net Revenue: 10 214
- EBITDA: -8 650
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-31
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Oncology Pharma Inc News
New
AstraZeneca’s growth engine stays on track despite cost pressures
AstraZeneca’s growth engine stays on track despite cost pressures Proactive uses images sourced from Shutterstock AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) full-year results showed the pharmaceutical...
Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance
Focused Execution Drives Strong Full-Year 2025 EPS Performance Enters 2026 with Clear Strategic Priorities and Growing Late-Stage Pipeline Advanced 11 Key Pivotal Study Starts in 2025 and ~20 Key Pivo...
McKesson Corporation Completes Divestiture of Norwegian Operations
IRVING, Texas, January 30, 2026--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) announced today that it has closed the transaction to sell its retail and distribution businesses in Norway to Norges...
Guardant Health Catapults 234%; Sets Up With Strong Sales Outlook
Medical services stock Guardant Health is Thursday's selection for IBD 50 Stocks To Watch after catapulting 234% in 2025, thanks to steady sales growth for its noninvasive cancer screening and diagnos...
Get Oncology Pharma Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
